ES513444A0 - "un procedimiento para preparar una forma de dosificacion unitaria adecuada para el tratamiento de una enfermedad asociada con un alelo de un gen de la respuesta inmune". - Google Patents

"un procedimiento para preparar una forma de dosificacion unitaria adecuada para el tratamiento de una enfermedad asociada con un alelo de un gen de la respuesta inmune".

Info

Publication number
ES513444A0
ES513444A0 ES513444A ES513444A ES513444A0 ES 513444 A0 ES513444 A0 ES 513444A0 ES 513444 A ES513444 A ES 513444A ES 513444 A ES513444 A ES 513444A ES 513444 A0 ES513444 A0 ES 513444A0
Authority
ES
Spain
Prior art keywords
wing
gene
preparing
procedure
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES513444A
Other languages
English (en)
Other versions
ES8307501A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of ES513444A0 publication Critical patent/ES513444A0/es
Publication of ES8307501A1 publication Critical patent/ES8307501A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES513444A 1981-06-25 1982-06-25 "un procedimiento para preparar una forma de dosificacion unitaria adecuada para el tratamiento de una enfermedad asociada con un alelo de un gen de la respuesta inmune". Expired ES8307501A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27739881A 1981-06-25 1981-06-25
US30459581A 1981-09-22 1981-09-22

Publications (2)

Publication Number Publication Date
ES513444A0 true ES513444A0 (es) 1983-08-01
ES8307501A1 ES8307501A1 (es) 1983-08-01

Family

ID=26958458

Family Applications (1)

Application Number Title Priority Date Filing Date
ES513444A Expired ES8307501A1 (es) 1981-06-25 1982-06-25 "un procedimiento para preparar una forma de dosificacion unitaria adecuada para el tratamiento de una enfermedad asociada con un alelo de un gen de la respuesta inmune".

Country Status (4)

Country Link
EP (1) EP0068790B1 (es)
JP (1) JP2555301B2 (es)
DE (1) DE3269354D1 (es)
ES (1) ES8307501A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59231024A (ja) * 1983-06-14 1984-12-25 Medekusu:Kk 自己免疫疾患に対する治療薬
JPS6011430A (ja) * 1983-06-30 1985-01-21 Medekusu:Kk 腎疾患に対する治療薬
JPS6041616A (ja) * 1983-08-12 1985-03-05 Medekusu:Kk 腎疾患に対する治療薬
DE3687064T2 (de) * 1985-06-14 1993-11-11 Bristol Myers Squibb Co Verfahren zur identifizierung von mit gesteigerter diabetesgefahr assoziierten allelen.
US6045796A (en) * 1992-12-17 2000-04-04 Anergen, Inc. Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease
US6180377B1 (en) * 1993-06-16 2001-01-30 Celltech Therapeutics Limited Humanized antibodies
CA2206471A1 (en) * 1994-12-07 1996-06-13 Hoffmann-La Roche Inc. Monoclonal antibody fragments having immunosuppressant activity
EP0800534A2 (en) * 1994-12-23 1997-10-15 Laboratoires Om S.A. Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
DE19531346A1 (de) * 1995-08-25 1997-02-27 Gsf Forschungszentrum Umwelt Arzneimittel zur Immuntherapie, enthaltend Antikörper, die spezifisch das MHCII-Antigen eines zu behandelnden Patienten erkennen

Also Published As

Publication number Publication date
EP0068790A3 (en) 1983-06-29
ES8307501A1 (es) 1983-08-01
DE3269354D1 (en) 1986-04-03
EP0068790B1 (en) 1986-02-26
EP0068790A2 (en) 1983-01-05
JP2555301B2 (ja) 1996-11-20
JPS5899422A (ja) 1983-06-13

Similar Documents

Publication Publication Date Title
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
FI822770A0 (fi) Bensazepin-2-oner, foerfarande foer deras framstaellning, farmaceutiska preparat innehaollande dessa foereningar samt deras terapeutiska anvaendning
IT1155619B (it) Bendaggio per la somministrazione di medicamenti
NO162941C (no) Maskin for vaksinering av fisk.
NO881482L (no) Fremgangsmaate for fremstilling av di-t-butylfenoler.
IT8221125A0 (it) Procedimento per la fabbricazione di vulcanizzati.
NO166494C (no) Fremgangsmaate for fremstilling av human lymfoblastoid interferon.
IT7926935A0 (it) Procedimento eterogeneo per lapreparazione di 1,1-diesteri.
ES513444A0 (es) "un procedimiento para preparar una forma de dosificacion unitaria adecuada para el tratamiento de una enfermedad asociada con un alelo de un gen de la respuesta inmune".
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
ES514572A0 (es) "un procedimiento para la preparacion de glutation".
IT8722911A0 (it) Procedimento per la preparazione di monosialoganglioside.
ES514571A0 (es) "un procedimiento para la preparacion de glutation".
ES510928A0 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
NO830294L (no) Medikamentinhalator.
ES513832A0 (es) "un procedimiento para la preparacion de fenetilpiperidinas".
IT8224818A0 (it) Procedimento per la preparazione del7-metil-3-metilen-7-otten-1-il-propionato.
ES514282A0 (es) "un procedimiento para la produccion de una medicina para inhalacion".
Winther Physical activity through the eyes of six-year olds
ES548863A0 (es) Un procedimiento para preparar el homero s de un 3-eter de 2-hidroxi -profil-amina.
IT8125628A0 (it) Procedimento per la preparazione di vaccino antitetanico.
IT8719073A0 (it) Procedimento per la preparazione di omega-isopropossifenolo.
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.
IT1137246B (it) Procedimento per la preparazione di un derivato del 2,4-diossacicloesanone

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020506